CSA Medical Inc is a Lexington-based company that has developed the RejuvenAir System, a breakthrough medical device designed to treat the underlying cause of Chronic Obstructive Pulmonary Disease (COPD) with Chronic Bronchitis. Unlike current medications, the RejuvenAir System offers a unique solution by applying a precise thermal dose of extremely cold liquid nitrogen to targeted areas within the lungs, rejuvenating the airways and allowing for the growth of new healthy cells.
With 9 million Americans suffering from COPD with Chronic Bronchitis, CSA Medical Inc's RejuvenAir System aims to provide a minimally invasive, outpatient bronchoscopic procedure that goes beyond symptom relief and addresses the root cause of the disease. By participating in their SPRAY-CB Clinical Trial, patients have the opportunity to explore this innovative treatment option and contribute to ongoing research on the safety and effectiveness of metered cryospray treatments for Chronic Bronchitis.
Generated from the website